{"nctId":"NCT02129608","briefTitle":"Low Level Laser Treatment (LLLT) and Lorcaserin for Weight Management","startDateStruct":{"date":"2014-06"},"conditions":["Overweight","Obese"],"count":44,"armGroups":[{"label":"LLLT","type":"ACTIVE_COMPARATOR","interventionNames":["Device: LLLT"]},{"label":"Lorcaserin","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Lorcaserin"]},{"label":"LLLT and Lorcaserin","type":"ACTIVE_COMPARATOR","interventionNames":["Device: LLLT","Drug: Lorcaserin"]}],"interventions":[{"name":"LLLT","otherNames":["Low Level Laser","Erchonia® Zerona™ 2.0 Laser"]},{"name":"Lorcaserin","otherNames":["Belviq"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* be 18-70 years of age;\n* have a body weight of greater than 50 kg (110 pounds);\n* have a BMI 27-39.9 kg/m2;\n* be weight concerned;\n* be motivated to reduce their central adiposity;\n* be able to participate fully in all aspects of the study;\n* have understood and signed study informed consent.\n\nExclusion Criteria:\n\n* have used weight loss medications or participated in a weight loss program within the past 30 days;\n* are currently taking supplements known to affect weight, such as garcinia cambrogia.\n* have had weight fluctuations of 20 pounds or more in the past 6 months (self-report);\n* have an implanted device (including pacemaker or lap band) in the targeted area of LLLT;\n* have an active untreated clinically significant psychiatric condition (psychosis, bipolar disorder, or depression);\n* have used an investigational drug within 30 days of study enrollment;\n* have a recent history (past 30 days) of alcohol or drug abuse or dependence;\n* are currently pregnant or lactating, or are of child-bearing potential or are likely to become pregnant during the medication phase and are unwilling to use a reliable form of contraception;\n* have a history of any major cardiovascular events including heart valve disease, cardiac arrhythmias, congestive heart failure, acute coronary syndrome, stroke, transient ischemic attack, or peripheral vascular disease;\n* have current uncontrolled hypertension (systolic \\> 165 mm Hg or diastolic \\> 95 mm Hg) documented on 2 separate occasions;\n* have clinically significant acute or chronic progressive or unstable neurologic, hepatic, renal, cardiovascular, lymphatic, respiratory, or metabolic disease (such as diabetes) or active cancer or are within 1 year of cancer remission;\n* Prior surgical intervention for body sculpting/weight loss, such as liposuction, abdominoplasty, stomach stapling, lap band surgery, etc.;\n* medical, physical, or other contraindications for body sculpting/weight loss;\n* current use of medication(s) known to affect weight levels/cause bloating or swelling and for which abstinence during the course of study participation is not safe or medically prudent;\n* concurrently taking a serotonergic drug (selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs), triptans, bupropion, dextromethorphan, St. John's Wort). These drugs can be used to treat depression and/or migraines but are contraindicated with lorcaserin;\n* any medical condition known to affect weight levels and/or to cause bloating or swelling;\n* diagnosis of, and/or taking medication for, irritable bowel syndrome;\n* active infection, wound or other external trauma to the areas to be treated with the laser;\n* known photosensitivity disorder;\n* are allergic to lorcaserin;\n* current active cancer or currently receiving treatment for cancer; or\n* have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence;","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","maximumAge":"70 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in Waist Circumference","description":"The change in waist circumference from baseline to 3 months","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.3","spread":"4.1"},{"groupId":"OG001","value":"-6.0","spread":"7.3"},{"groupId":"OG002","value":"-4.0","spread":"5.5"}]}]}]},{"type":"PRIMARY","title":"Change in Weight","description":"The change in weight from baseline to 3 months","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.0","spread":"4.4"},{"groupId":"OG001","value":"-3.7","spread":"3.3"},{"groupId":"OG002","value":"-3.5","spread":"3.6"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":15},"commonTop":["nausea","Headache","dizziness","Low Blood Pressure","Tingling"]}}}